Calcipotriol hydrate / hydrocortisone - paediatric investigation plan

Calcipotriol hydrate

hydrocortisone

Key facts

• Active Substance:
  • Calcipotriol hydrate
  • hydrocortisone
• Therapeutic area:
  Dermatology
• Decision number:
  P/69/2009
• PIP number:
  Calcipotriol hydrate / hydrocortisone
• Pharmaceutical form(s):
  Ointment
• Condition(s) / indication(s):
  Psoriasis vulgaris
• Route(s) of administration:
  Cutaneous use
• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  20/04/2009

Decision

P/69/2009: European Medicines Agency decision of 20 April 2009 on the agreement of a Paediatric Investigation Plan and on the granting of a deferral and on the granting of a waiver for calcipotriol hydrate / hydrocortiso...

AdoptedReference Number: EMEA/231675/2009